Hillhouse-backed Genor Biopharma plans $200m HK IPO

Hillhouse-backed Genor Biopharma plans $200m HK IPO

Genor Biopharma Co. is planning an initial public offering in Hong Kong that could raise about $200 million, according to people familiar with the matter.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter